Hodgkin lymphoma: open trials in Japan

5 open trials have a site in Japan. Registry data; only the trial team decides who can take part.

NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
National Hospital Organization Nagoya Medical Center, Nagoya · The Cancer Institute Hospital of JFCR, Tokyo
Registry updated 2026-11-04
NCT07226843
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Trial Treatment · Phase 1 · Eli Lilly and Company
National Cancer Center Hospital East, Chiba · Okayama University Hospital, Okayama · Cancer Institute Hospital of JFCR, Tokyo
Registry updated 2026-11-04
NCT06526793
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Trial Treatment · Phase 2 · AstraZeneca
Chiba · Kashiwa · Kōtoku · Kumamoto · Niigata · Okayama · Osaka · Yokohama
Registry updated 2026-10-14
NCT06137144
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Trial Treatment · Phase 1/2 · AstraZeneca
Bunkyō City · Kōtoku
Registry updated 2026-10-13
NCT05481437
A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma
Research · Takeda
Tokyo
Registry updated 2026-04-13

This page is not medical advice. Talk to your doctor before contacting a trial.

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring